GlobalData at ISPOR Europe in Vienna – come see our posters!

GlobalData is pleased to be attending the Professional Society for Health Economics and Outcomes Research (ISPOR) Europe Conference from 6–9 November 2022. Please look out for Gustav Ando, Milena Izmirlieva, Sara Trenti, Sara Cesarec and Elliot Trofimowicz. GlobalData will be presenting the following posters:

Free Report

How is the Biopharmaceutical industry evolving?

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects. Access the report to:

Benchmark the impact of major themes on the Biopharmaceutical industry.
Gain a deeper "on the ground" perspective through exclusive opinions and analysis from industry respondents.
Evaluate the effects of COVID-19 on the sector.

Download the full report to understand what to expect and how to align your strategies for success.

By downloading this case study, you acknowledge that GlobalData may share your information with GlobalData and that your personal data will be used as described in their Privacy Policy Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

HPR82: Price Leakage Due to International Reference Pricing: Impact of Pfizer’s Not-for-Profit Pricing Initiative for LMICs on Price Levels in Other Countries, Izmirlieva MA
- In-Person and Virtual Poster Session 2
- Date: Monday 7 November 2022
- Poster Session Time: 15:00–18:15
HPR110: ESG in Pharma Procurement, Not More Than Wishful Thinking? A Quantitative View on Award Criteria in Tenders in the EU5 from 2011 to 2020, Genane C, Trenti S
- In-Person and Virtual Poster Session 3
- Date: Tuesday 8 November 2022
- Poster Session Time: 10:00–13:15
HPR150: P&R Policies and Macro-Trends Pertinent to CGTs: Where Are the Main Barriers and Who Leads the Efforts to a Greater Access? Cesarec S, Trenti S, Norwood-Knutsson C
- In-Person and Virtual Poster Session 4
- Date: Tuesday 8 November 2022
- Poster Session Time: 15:00–18:15
HPR188: Characterizing the Relevance of IRP for Medical Devices: A Cross-Country Comparison, Trenti S, Cesarec S, Solomonides P
- In-Person and Virtual Poster Session 5
- Date: Wednesday 9 November 2022
- Poster Session Time: 09:00–12:30

Free Report

How is the Biopharmaceutical industry evolving?

Benchmark the impact of major themes on the Biopharmaceutical industry.
Gain a deeper "on the ground" perspective through exclusive opinions and analysis from industry respondents.
Evaluate the effects of COVID-19 on the sector.

Download the full report to understand what to expect and how to align your strategies for success.

By GlobalData